Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Sell
17
SHWZ Quote, Financials, Valuation and Earnings
Last price:
$0.05
Seasonality move
:
11.1%
Day range:
$0.01 - $0.13
52-week range:
$0.01 - $1.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.02x
P/B ratio:
0.04x
Volume:
39K
Avg. volume:
23.5K
1-year change:
-91.23%
Market cap:
$4M
Revenue:
$172.4M
EPS (TTM):
-$0.81
Analysts' Opinion
-
Consensus RatingMedicine Man Technologies has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Medicine Man Technologies has an estimated upside of 5180.66% from its current price of $0.05.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.05.
Fair Value
-
According to the consensus of 0 analysts, Medicine Man Technologies has 5180.66% upside to fair value with a price target of -- per share.
SHWZ vs. S&P 500
-
Over the past 5 trading days, Medicine Man Technologies has underperformed the S&P 500 by -0.67% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medicine Man Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medicine Man Technologies has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Medicine Man Technologies reported revenues of $43.2M.
Earnings Growth
-
Medicine Man Technologies earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Medicine Man Technologies reported earnings per share of -$0.20.
Enterprise value:
155M
EV / Invested capital:
--
Price / LTM sales:
0.02x
EV / EBIT:
95.29x
EV / Revenue:
0.88x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
97.79x
Price / Operating cash flow:
34.68x
Enterprise value / EBITDA:
9.45x
Gross Profit (TTM):
$72M
Return On Assets:
-14.27%
Net Income Margin (TTM):
-28.59%
Return On Equity:
-39.36%
Return On Invested Capital:
-17.94%
Operating Margin:
-6.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $134.4M | $165.7M | $175.7M | $42.4M | $43.2M | |
| Gross Profit | $63.3M | $91.7M | $72M | $24.5M | $19M | |
| Operating Income | $11.7M | $27.2M | -$3.3M | $5M | -$2.7M | |
| EBITDA | $55.7M | $39.5M | $16.4M | $11.1M | -$1.5M | |
| Diluted EPS | -$0.22 | -$0.74 | -$0.81 | -$0.15 | -$0.20 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $10M | $35.5M | $66.8M | $66.5M | $46.3M | |
| Total Assets | $36M | $183.4M | $318.1M | $369M | $339.6M | |
| Current Liabilities | $6.7M | $13.1M | $28.6M | $49.8M | $85.3M | |
| Total Liabilities | $8.5M | $71.4M | $161.2M | $220.9M | $248.8M | |
| Total Equity | $27.5M | $111.9M | $157M | $148.1M | $90.8M | |
| Total Debt | -- | $54.3M | $121.1M | $155.4M | $163.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2022-12-31 | 2023-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $8.4M | $6.7M | $12.2M | $6.3M | $3.5M | |
| Cash From Investing | -$81.2M | -$75M | -$26.4M | -$5.6M | -$1.2M | |
| Cash From Financing | $177.9M | -- | -- | -$436.9K | -$2.7M | |
| Free Cash Flow | $2.7M | -$7.3M | $1.6M | $4.8M | $2.3M | |
SHWZ
Sector
Market Cap
$4M
$45.9M
Price % of 52-Week High
3.23%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-91.23%
-32.15%
Beta (5-Year)
1.838
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$0.03
200-day SMA
Sell
Level
$0.33
Bollinger Bands (100)
Sell
Level
0.07 - 0.19
Chaikin Money Flow
Buy
Level
2.7M
20-day SMA
Sell
Level
$0.06
Relative Strength Index (RSI14)
Sell
Level
47.16
ADX Line
Buy
Level
19.93
Williams %R
Neutral
Level
-66.6667
50-day SMA
Sell
Level
$0.10
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Sell
Level
-4.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4322)
Sell
CA Score
(Annual)
Level (-0.6385)
Buy
Beneish M-Score
(Annual)
Level (-3.1041)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (2.1339)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company’s business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.
Stock Forecast FAQ
In the current month, SHWZ has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SHWZ average analyst price target in the past 3 months is --.
-
Where Will Medicine Man Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medicine Man Technologies share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Medicine Man Technologies?
Analysts are divided on their view about Medicine Man Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medicine Man Technologies is a Sell and believe this share price will drop from its current level to --.
-
What Is Medicine Man Technologies's Price Target?
The price target for Medicine Man Technologies over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SHWZ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medicine Man Technologies is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SHWZ?
You can purchase shares of Medicine Man Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medicine Man Technologies shares.
-
What Is The Medicine Man Technologies Share Price Today?
Medicine Man Technologies was last trading at $0.05 per share. This represents the most recent stock quote for Medicine Man Technologies. Yesterday, Medicine Man Technologies closed at $0.05 per share.
-
How To Buy Medicine Man Technologies Stock Online?
In order to purchase Medicine Man Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
